Track market-moving stories before they get noisy

Bluetooth® 6 SoC combines Channel Sounding, Secure Vault™ High security, and integrated CAN-FD and peripherals to enable smaller, longer-lasting IoT devices with lower system cost

, /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless connectivity, today announced the BG2B, its next Series 2Bluetooth® Low Energy (LE) wireless SoC designed to help developers build smaller, more secure, and longer-lasting battery-powered IoT devices by providing the industry's best combination of power efficiency, security, and integrations.

The new BG2B wireless SoC from Silicon Labs. As Bluetooth LE applications become more sophisticated, developers are challenged to add capabilities such as secure ranging, location awareness, advanced security, and richer peripheral integration while preserving battery life and compact designs expected of today's wireless IoT devices. BG2B addresses these demands with Silicon Labs' lowest-power Bluetooth architecture, a complete feature set for Bluetooth Channel Sounding, Secure Vault™ High security and integrated peripherals including CAN-FD, LED drivers and dual ADCs, in a single highly integrated platform.

Designed for applications including secure ranging, asset tracking, electronic shelf labels (ESLs), smart home, industrial monitoring, and vehicle diagnostics, BG2B helps developers extend battery life while preparing for more demanding Bluetooth LE applications.

"Bluetooth LE is moving beyond basic connectivity into secure ranging, proximity awareness, and location-aware experiences, while customers still need the low power, small form factor, and cost efficiency that made Bluetooth the foundation of battery-powered IoT," said Daniel Cooley, SVP and CTO, Silicon Labs. "BG2B brings these requirements together in a single platform, combining our lowest-power Bluetooth LE architecture to date with advanced Channel Sounding, Secure Vault™ High security, and integrated peripherals that help customers build more capable, connected products with fewer external components."

A New Standard for Ultra-Low-Power Bluetooth

Battery life remains one of the biggest challenges for battery-powered IoT devices as products continue adding more sensing, intelligence, and wireless capabilities. BG2B features a dual-output DC-DC power architecture and multi-core design that significantly improves efficiency across active, receive, and sleep modes.

BG2B is the lowest-power Bluetooth LE device in Silicon Labs' portfolio, delivering 14%-15% lower MCU active current, lower Bluetooth receive current, and 1.1 µA EM2 sleep current with RAM retention as compared to the Silicon Labs' previous lowest power Bluetooth LE SoC, enabling longer battery life for sleepy products such as wireless sensors, asset tags, smart locks, remotes, wearables, and electronic shelf labels.

Enhanced Channel Sounding with Expanded Peripherals

For developers building location-aware products today, BG2B supports advanced Bluetooth Channel Sounding capabilities including Mode 3, Normalized Attack Detector Metric (NADM), and Inline Phase Correction Term (Inline PCT). Designed to meet Apple and Google Bluetooth Channel Sounding specifications, BG2B helps developers build interoperable products across the industry's leading mobile ecosystems, supported by Silicon Labs' complete Channel Sounding development solution, including a royalty-free ranging library, software, tools, and engineering support.

Building on previous Silicon Labs Channel Sounding solutions, BG2B delivers even lower energy per ranging event through shorter Channel Sounding step timings, lower active current, and lower Bluetooth LE receive current.

In addition, BG2B integrates a broad set of peripherals that simplify system design while reducing BOM cost and PCB area.

The SoC combines Bluetooth LE with integrated CAN-FD, enabling wireless diagnostics and monitoring for commercial vehicles, fleet management, industrial equipment, and maintenance applications without requiring a separate Bluetooth bridge device.

Integrated LED boost and four-channel LED sink capabilities eliminate external LED driver circuitry, making BG2B well suited for electronic shelf labels, smart retail devices, and battery-powered products requiring RGBW LED for status indication.

Additional integrated capabilities include dual 12-bit ADCs for simultaneous analog sampling, Variable Resistive Load (VRL) for more accurate battery health estimation, to go along with expanded memory and a broad set of communication peripherals helping developers build more capable IoT devices while reducing external components.

Built for Tomorrow's Security Requirements

As connected devices face increasingly stringent cybersecurity requirements, BG2B incorporates Silicon Labs' Secure Vault™ technology to protect device identity, firmware, cryptographic keys, and sensitive data.

Designed to support PSA Level 3 compliance, BG2B helps manufacturers prepare for evolving security requirements such as the European Union Cyber Resilience Act. Combined with Silicon Labs' Custom Part Manufacturing Service (CPMS), developers can securely provision devices with unique identities, certificates, and cryptographic credentials during manufacturing.

Availability

BG2B SoCs are currently available through an early customer engagement program. Initial production hardware, including modules, are planned for 2027.

For more information about BG2B, read the post on the Silicon Labs blog.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers with the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in smart home, industrial IoT, and smart cities markets. Learn more at https://www.silabs.com.

SOURCE Silicon Labs

Shares of Arm Holdings (ARM -0.26%) were pulling back last month on broader concerns about the AI boom, and as the stock may have gotten overheated in the second quarter.

Chip stocks fell broadly last month as investors questioned the durability of the AI boom, including whether hyperscalers would earn a return on investment for the massive capital expenditures they are pouring into AI infrastructure.

According to data from S&P Global Market Intelligence, the stock finished the month down 34%. As you can see from the chart below, Arm fell in tandem with the VanEck Semiconductor ETF, though it experienced an outsize decline due to its high valuation.

ARM data by YCharts

What happened with Arm There was relatively little company-specific news out on Arm last month, with the exception of its earnings report at the end of the month, which actually sent the stock higher.

Several Wall Street analysts adjusted their price targets and ratings on the stock over the course of the month. HSBC lowered its rating from buy to hold with a price target of $315, primarily on valuation concerns. The firm noted that the surge in the stock that followed the "Arm Everywhere" event in March, when it launched its new AGI CPU, meant its long-term growth is already priced in.

Other comments also noted that capacity constraints could hold back the company's growth over the coming quarters, as well as weakness in the smartphone market, pressuring its growth.

In its fiscal first-quarter earnings report, the company edged out estimates on the top and bottom lines with solid growth in both royalties and licensing revenue. Data center royalty revenue more than doubled once again, and that segment is on its way to becoming Arm's biggest, topping smartphones.

Second-quarter guidance was also better-than-expected, and the stock bounced the next day with the help of the rally in the AI sector after Ken Griffin's Citadel bought a portfolio of AI stocks valued at more than $10 billion from Situational Awareness, which was facing a margin call.

Image source: The Motley Fool.

What's next for Arm Arm is set to begin shipping the new AGI CPU in the fiscal fourth quarter, which ends in March. That will be a big test for the company, and the stock could jump if the rollout goes well. Demand is already outstripping supply, and the company guided to $15 billion in CPU revenue and $25 billion in overall revenue in fiscal 2031. It also forecast adjusted earnings per share of $9 that year.

How Arm performs relative to that forecast will determine how the stock does over the coming years. The next few quarters should offer some key clues where it's headed.

HSBC Holdings is an advertising partner of Motley Fool Money. Jeremy Bowman has positions in Arm Holdings and VanEck ETF Trust-VanEck Semiconductor ETF. The Motley Fool has positions in and recommends Arm Holdings. The Motley Fool recommends HSBC Holdings. The Motley Fool has a disclosure policy.

@Algorand's x402 integration is generating real on-chain activity, with more than 160,000 transactions and over $110,000 in volume settled through the GoPlausible facilitator. The numbers underscore growing developer interest in the pay-per-request standard, which was originally built for Base but is now finding a foothold on Algorand.

What is x402 and why does Algorand fit? x402 is an open protocol that embeds payment logic directly into HTTP requests. Originally developed by Coinbase, it enables AI agents and services to transact per call without API keys or billing infrastructure. Algorand's low fees, instant finality, and deterministic execution model allow HTTP payment requests to pair with on-chain settlement without breaking synchronous request-response patterns, making x402 practical not just as a concept but as an internet-native payment mechanism that can operate at scale.

Built by Coinbase around the HTTP 402 status code, the x402 protocol enables users to pay for resources via API without registration, emails, OAuth, or complex signatures, with Algorand support provided by the Algorand Foundation and GoPlausible.

Global x402 Challenge: what is at stake The Algorand Foundation launched the Global x402 Challenge, a five-month competition for developers building x402-powered, pay-per-request API services on Algorand mainnet. The top five finalists share $100,000 USD, with an additional 500,000 ALGO split across the top 20 endpoints on the leaderboard.

To enter, developers must deploy a paid x402 endpoint on Algorand Mainnet. Usage is tracked automatically via the GoPlausible facilitator on a public leaderboard, and the top 50 qualify for 10 finalist spots who will present live, in-person or virtually, at Devcon 8 India. Registration closes at 11:45 p.m. Eastern Standard Time on September 1, 2026.

The @AlgoFoundation is also hosting a Reddit AMA on the competition this Thursday, August 6, giving developers a direct line to the team behind the challenge. The competition follows a busy run of builder events: the Algorand Builders Berlin: Agentic Commerce x402 Hackathon in June drew more than 100 builders for a 36-hour sprint, with winning projects ranging from an agentic trust layer for regulated finance to a peer-to-peer energy market where an EV agent settles solar power purchases in real time.

Projects will be evaluated on real usage, use case quality, technical execution, and long-term potential. For builders still exploring ideas, the Algorand developer pages outline use cases including paid data access, autonomous agent tooling, and usage-based billing across microservices.

Sources
Algorand Foundation: Global x402 Challenge official page
Crypto Reporter: Algorand Foundation Launches Global x402 Challenge
Algorand Blog: x402, Unlocking the Agentic Commerce Era

Some older Ford cars and SUVs pose "unreasonable" ​safety risks, according to federal regulators, warning that the timing belt may fail, causing them to lose ‌power or engines to seize.

The National Highway Traffic Safety Administration announced on Monday that it has upgraded a defect investigation into 135,551 Ford vehicles from model years between 2014 and 2021 that are powered by the small 1.0L turbocharged three-cylinder engine due to an "unreasonable risk to motor vehicle safety."

The three affected models, the Fiesta, Focus and EcoSport, have all been discontinued by Ford.

The NHTSA said it ​was aware of 355 incidents alleging a low engine oil pressure warning light ​appeared just before a complete loss or reduction of motive power while driving.

FORD RECALLS NEARLY 388,000 VEHICLES OVER SECOND-ROW SEAT INJURY HAZARD

Some older Ford cars and SUVs pose "unreasonable" ​safety risks. (Photo by National Motor Museum/Heritage Images via Getty Images / Getty Images)

NHTSA said its initial investigation revealed timing belt material may degrade and create debris that clogs the mesh oil pump pick-up screen, causing reduced engine oil pressure.

The probe suggests failures can happen without sufficient warning and loss of power or engine seizure is imminent. Failures have been reported despite proper and routine oil maintenance, the NHTSA said.

"Based on NHTSA’s analysis ​of the data, failure rates, information provided by Ford, preliminary engine teardown analysis, and precedent recalls ​regarding loss of engine oil pressure with the presence of driver facing warnings, (the agency) believes there is an ‌unreasonable ⁠risk to motor vehicle safety," the NHTSA said.

FORD RECALLS MORE THAN 110,000 MUSTANG VEHICLES OVER WINDSHIELD WIPER, DRIVETRAIN DEFECTS

The National Highway Traffic Safety Administration said it has upgraded a defect investigation into 135,551 Ford vehicles. (Getty Images / Getty Images)

NHTSA's decision to upgrade the probe to an engineering analysis is a required step before it could force the automaker to issue a recall.

Some drivers reported engine failures that cost thousands of dollars to fix.

One 2017 Ford Focus driver reported being on a highway in Wilmington, Delaware, when the oil pressure light illuminated and within an eighth of a mile, ​the vehicle "lost ​all power and the ⁠engine began to sound like a tank."

Data showed an average failure mileage of roughly ​70,000 miles, and 98% of the failures happened before ​the 150,000-mile suggested ⁠timing belt replacement, the NHTSA said.

The three affected models, the Fiesta, Focus and EcoSport, have all been discontinued by Ford. (Jeff Kowalsky/Bloomberg via Getty Images  / Getty Images)

CLICK HERE TO GET FOX BUSINESS ON THE GO

In June, Ford told the safety regulator it was adopting a non-safety customer satisfaction program for global vehicles with a 1.0L Fox Classic Timing Belt, cutting the maintenance interval to 100,000 ⁠miles or ​six years.

Ford is offering reimbursement to eligible customers who ​previously purchased engine repairs or replacements due to a timing belt-related issue, the NHTSA said, although it was not immediately clear which ​vehicles are covered by the customer satisfaction program.

Reuters contributed to this report.

Monday, 03 August 2026 09:00 PM

Topic: 

Earnings Second Quarter 2026 Highlights

Net Income - $1.9 million

Bank Net Income - $2.1 million

TBVPS - $12.88

Diluted EPS- $0.24

SCOTTSDALE, AZ / ACCESS Newswire / August 3, 2026 / Bancorp 34, Inc. (OTCID:BCTF), the parent company for Southwest Heritage Bank, together, the "Company" reports second quarter of 2026 performance.

Management Comments - Ciaran McMullan, Chairman & CEO

Core1 ROATA improved for the seventh consecutive quarter.

Core1 Net Interest Margin also improved over both the linked and prior year quarters.

While total loans increased modestly over the linked quarter, we booked approximately $37.0 million in new commitments.

Non-performing assets declined significantly as we returned a single large relationship to accrual status.

The bank received approval to retire $23.0 million of subordinated debt, effective July 15th, 2026.

As a result, annual interest cost will decline by $920,000.

During the quarter, we appointed a new Market President for our Las Cruces / El Paso market

2Q26 Highlights

Net Income and NIM

Core1 NIM improved over the linked and prior year quarters, by 8bps and 22bps, respectively driven by declining deposit costs and improved loan portfolio yields.

Net Income improved over the linked quarter driven primarily by increased net interest income and declined over the prior year due to the impact of a large recovery in Q2 2025.

Net Operating Income (pre-tax pre-provision) increased over both the linked and prior year quarters due to improved NIM and non-interest income.

Non-interest expense increased slightly during the quarter due to one-time costs related to the relocation of our Scottsdale Branch.

Balance Sheet

Deposits declined by $29.0 million in line with historical trends primarily due to tax payments coming due in April.

Total loans were up only slightly as elevated payoffs offset the impact of $37.0 million in new loan commitments.

Asset Quality

NPAs3 improved significantly, declining to 0.31% due to the upgrade of a single relationship of approximately $7.0 million.

Capital

TBVPS increased by $0.32, including a modestly negative AOCI impact.

The bank's Tier 1 Leverage Ratio increased to 13.36%.

Performance Metrics
(Consolidated)

2Q26

1Q26

2Q25

ROATA

0.83

%

0.75

%

1.01

%

ROATE

8.09

%

7.41

%

11.14

%

Core1 ROATA

0.68

%

0.65

%

0.51

%

Core1 ROATE

6.74

%

6.41

%

5.56

%

Net Interest Margin

3.85

%

3.86

%

3.66

%

Cost of Funds

2.46

%

2.47

%

2.61

%

Overhead Ratio2

2.85

%

2.86

%

2.84

%

Efficiency Ratio

73.47

%

75.50

%

79.07

%

NPA3

0.31

%

1.07

%

0.18

%

ACL to Total Loans

1.23

%

1.31

%

1.55

%

Balance Sheet (in 000s)

2Q26

1Q26

2Q25

Total Assets

$

895,991

$

918,984

$

931,267

Total Loans

$

707,154

$

706,062

$

676,389

Total Deposits

$

752,230

$

781,585

$

795,104

Total Capital

$

100,168

$

98,137

$

92,242

TBVPS

$

12.88

$

12.56

$

11.39

Income Statement

(000s except EPS)

2Q26

1Q26

2Q25

Net Interest Income

$

8,365

$

8,206

$

8,096

Non-interest Income

$

484

$

230

$

292

Non-interest Expense

$

6,501

$

6,369

$

6,633

Net Operating Income

$

2,348

$

2,067

$

3,005

Net Income

$

1,867

$

1,654

$

2,330

Core1 Net Income

$

1,560

$

1,430

$

1,163

Diluted Earnings per Share

$

0.24

$

0.21

$

0.32

1 - Non-GAAP, excludes merger related accretion and amortization, as well as material non-recurring income and expense items.

2 - Non-interest expense as a percentage of average assets

3 - NPA is non-performing assets as a % of total assets, net of government guarantees.

ABOUT BANCORP 34, INC. - Bancorp 34 is the holding company for Southwest Heritage Bank. The bank's headquarters are located at 8777 East Hartford Drive, Suite 100, Scottsdale, Arizona 85255. In addition, we operate seven full-service community bank branches, two in Maricopa County, Arizona, in the cities of Scottsdale and Gilbert; three in Pima County, Arizona, in the cities of Tucson and Green Valley; one branch in Otero County, New Mexico in the city of Alamogordo; and one branch in Dona Ana County New Mexico, in the city of Las Cruces.

FORWARD-LOOKING STATEMENTS - Certain statements herein constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by words such as "believes," "will," "expects," "project," "may," "could," "developments," "strategic," "launching," "opportunities," "anticipates," "estimates," "intends," "plans," "targets" and similar expressions. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ materially from those set forth in the forward-looking statements as a result of numerous factors. Factors that could cause such differences to exist include, but are not limited to, general economic conditions, changes in interest rates, the effects of any health pandemic, regulatory considerations, competition and the other risks. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Forward-looking statements speak only as of the date they are made, and we assume no obligation to update any of these statements in light of new information, future events or otherwise unless required under federal securities laws.

NON-GAAP FINANCIAL MEASURES- Some of the financial measures included in this release are not measures of financial performance recognized in accordance with generally accepted accounting principles in the United States ("GAAP"). These non-GAAP financial measures include: (i) core net income; (ii) core net interest margin; (iii) core ROAA; (iv) core ROAE (v) core ROATA; (vi) core ROATE; (vii) core NIE to average assets; and (viii) core efficiency ratio. We believe these non-GAAP financial measures provide investors and management with a more complete understanding of our financial position and performance. These non-GAAP financial measures are supplemental and are not a substitute for any analysis based on GAAP financial measures. Not all companies use the same calculation of these measures; therefore, this presentation may not be comparable to other similarly titled measures as presented by other companies. A reconciliation of our non-GAAP financial measures to the comparable GAAP financial measures is included at the end of the financial statement tables.

Select Financial Ratios

2Q26

1Q26

2Q25

Return on Average Assets (ROAA)

0.82

%

0.74

%

1.01

%

Core4 ROAA

0.68

%

0.64

%

0.50

%

Return on Average Tangible Assets (ROATA)

0.83

%

0.75

%

1.01

%

Core4 ROATA

0.69

%

0.65

%

0.51

%

Return on Average Equity (ROAE)

7.52

%

6.84

%

9.93

%

Core4 ROAE

6.27

%

5.91

%

5.23

%

Return on Average Tangible Equity

8.09

%

7.41

%

11.14

%

Core4 ROATE

6.74

%

6.41

%

5.56

%

Overhead Ratio

2.85

%

2.86

%

2.84

%

Core4 Overhead Ratio

2.71

%

2.65

%

2.65

%

Efficiency Ratio

73.47

%

75.50

%

79.07

%

Core4 Efficiency Ratio

76.14

%

76.92

%

82.26

%

Net Interest Margin

3.85

%

3.86

%

3.66

%

Core5 Net Interest Margin

3.50

%

3.42

%

3.28

%

Cost of Funds

2.46

%

2.47

%

2.61

%

Earnings Per Share (EPS)

$

0.25

$

0.22

$

0.32

Diluted EPS

$

0.24

$

0.21

$

0.32

Bank Regulatory Capital Ratios

2Q26

1Q26

2Q25

Tier 1 Leverage Capital Ratio

13.36

%

13.16

%

11.86

%

Common Equity Tier 1 Capital Ratio

15.11

%

14.71

%

14.18

%

Tier 1 Capital Ratio

15.11

%

14.71

%

14.18

%

Total Risk-based Capital Ratio

16.26

%

15.93

%

15.44

%

Credit Quality6

2Q26

1Q26

Total Classified Loans

$

16,311

$

18,299

Classified - Accrual Loans

$

13,522

$

7,339

Classified - Non-Accrual Loans

$

2,789

$

10,960

Non-Performing Assets

$

2,789

$

10,960

Total Classified / Total Loans

2.31

%

2.59

%

Adversely Classified Items/Total Capital

12.09

%

14.39

%

Period

GAAP Net
Income

Loan Mark
Accretion

CDI

Amortization

Non-Recurring
Items7

Core Net
Income8

2Q26

$

1,867

$

-679

$

349

$

-84

$

1,556

1Q26

$

1,654

$

-855

$

360

$

196

$

1,430

2Q25

$

2,330

$

-758

$

399

$

-1,197

$

1,163

4 - Non-GAAP, excludes merger related accretion and amortization, as well as material non-recurring income and expense items.
5 - Non-GAAP, excludes merger related fair value mark accretion and amortization.
6 - Classified and non-performing assets are net of government guarantees
7 - Includes Loan ACL reverse provision
8 - Non-GAAP, Assumes 25% tax rate

BALANCE SHEET (in 000s)

2Q26

1Q26

2Q25

Assets

Cash and due from banks

3,244

3,494

3,645

Fed funds sold & repos

5,540

1,040

5,430

Interest bearing deposits with banks

38,657

61,403

95,086

Investment securities

97,413

103,815

104,455

Loans, net of unearned income

707,154

706,062

676,389

Allowance for credit losses

-8,710

-9,258

-10,492

Premises and equipment, net

8,832

11,040

11,565

Accrued interest receivable

2,689

2,645

2,559

Core deposit intangible

5,328

5,677

6,791

Other assets

35,844

33,066

35,839

Total Assets

895,991

918,984

931,267

Liabilities

Non-interest bearing deposits

157,766

165,202

168,931

Interest bearing demand deposits

100,000

104,519

105,630

Savings and money market deposits

339,574

353,244

307,474

Time deposits - retail

152,350

155,721

207,999

Time deposits - wholesale

2,540

2,540

5,070

Total Deposits

752,230

781,226

795,104

Accrued expenses and other liabilities

16,273

12,322

16,680

Other borrowings

27,319

27,299

27,241

Total Liabilities

795,822

820,847

839,025

Equity

Common stock

74

74

75

Capital surplus

66,610

66,402

67,652

Retained earnings

33,850

33,850

25,989

Accumulated other comprehensive loss

-3,887

-3,843

-4,849

Net income

3,522

1,654

4,638

Unearned ESOP shares

0

0

-1,263

Total Equity

100,169

98,137

92,242

Total Liabilities & Equity

895,991

918,984

931,267

UNAUDITED

INCOME STATEMENT (in 000s)

2Q26

1Q26

2Q25

Interest Income

Interest on Loans

11,659

11,338

11,008

Fees on Loans

69

133

173

Interest on federal funds sold

32

33

49

Interest on deposits with banks

479

310

1,095

Investment Securities - Taxable

1,028

1,218

1,162

Total Interest Income

13,267

13,032

13,487

Interest Expense

Interest bearing demand deposits

369

349

373

Savings and Money Market Deposits

2,835

2,640

2,498

Time Deposits - Retail

1,336

1,469

2,124

Time Deposits - Wholesale

25

31

52

Total Interest Expense on Deposits

4,565

4,489

5,047

Interest on other borrowings

337

337

344

Total Interest Expense

4,902

4,826

5,391

Net Interest Income

8,365

8,206

8,096

Provision for Credit Losses

0

0

-1,250

Net In. Inc. After Prov. for Credit Losses

8,365

8,206

9,346

Non Interest Income

Service charges and fees

146

125

148

Mortgage loan and related fees

53

31

-9

Other noninterest income

285

74

153

Total Non Interest Income

484

230

292

Non Interest Expense

Salaries and employee benefits

3,420

3,451

3,323

Occupancy

773

725

726

Other noninterest expense

2,308

2,193

2,584

Total Non Interest Expense

6,501

6,369

6,633

Income Before Taxes

2,348

2,067

3,005

Income taxes

481

413

675

Net Income

1,867

1,654

2,330

INCOME STATEMENT (in 000s)

6 months
ending 2Q26

6 months
ending 2Q25

Interest Income

Interest on Loans

22,996

22,165

Fees on Loans

202

323

Interest on federal funds sold

65

101

Interest on deposits with banks

789

2,359

Investment Securities - Taxable

2,247

2,135

Total Interest Income

26,299

27,083

Interest Expense

Interest bearing demand deposits

718

702

Savings and Money Market Deposits

5,475

4,886

Time Deposits - Retail

2,804

4,570

Time Deposits - Wholesale

57

114

Total Interest Expense on Deposits

9,054

10,272

Interest on other borrowings

673

694

Total Interest Expense

9,727

10,966

Net Interest Income

16,572

16,117

Provision for Credit Losses

0

-2,750

Net In. Inc. After Prov. for Credit Losses

16,572

18,867

Non Interest Income

Service charges and fees

272

302

Mortgage loan and related fees

86

27

Other noninterest income

357

227

Total Non Interest Income

715

556

Non Interest Expense

Salaries and employee benefits

6,871

6,901

Occupancy

1,499

1,426

Other noninterest expense

4,501

5,098

Total Non Interest Expense

12,871

13,425

Income Before Taxes

4,416

5,998

Income taxes

894

1,360

Net Income

3,522

4,638

Average Balance Sheet and Yields

For the Three Months Ended

June 30, 2026

March 31, 2026

Average Balance

Interest

Average Yield/Rate

Average
Balance

Interest

Average Yield/Rate

Interest Earning Assets:

Federal funds sold

$

3,521,978

$

32,189

3.67

%

$

3,649,944

$

33,244

3.69

%

Deposits with banks

54,403,513

479,362

3.53

%

36,988,630

309,723

3.40

%

Investment securities

106,258,336

1,028,148

3.88

%

110,477,352

1,218,027

4.47

%

Loans

708,187,996

11,727,349

6.64

%

710,396,489

11,471,365

6.55

%

Total Interest Earning Assets

$

872,371,823

$

13,267,048

6.10

%

$

861,512,415

$

13,032,359

6.13

%

Non-Interest Earning Assets

$

41,795,279

$

41,417,194

Total Assets

$

914,167,102

$

902,929,609

Interest Bearing Liabilities:

Interest bearing demand

$

104,563,048

$

369,136

1.42

%

$

102,078,048

$

349,075

1.39

%

Savings and Money Market

347,058,899

2,835,039

3.28

%

327,965,659

2,639,522

3.26

%

Time deposits - Retail

155,333,571

1,335,594

3.45

%

165,714,505

1,468,887

3.59

%

Time Deposits - Wholesale

2,540,000

25,650

4.05

%

3,158,444

31,554

4.05

%

Total Interest Bearing Deposits

609,495,518

4,565,419

3.00

%

598,916,656

4,489,038

3.04

%

Total Borrowed Funds

27,307,385

336,310

4.94

%

27,287,777

336,989

5.01

%

Total Interest Bearing Liabilities

636,802,903

4,901,729

3.09

%

626,204,433

4,826,027

3.13

%

Non-Interest Bearing Deposits

162,926,161

-

0.00

%

165,855,529

-

0.00

%

Total Funding Sources/Cost

799,729,064

4,901,729

2.46

%

792,059,962

4,826,027

2.47

%

Non-Interest Bearing Liabilities

14,870,604

12,781,143

Equity

99,567,434

98,088,504

Total Liabilities and Equity

$

914,167,102

$

902,929,609

Net Interest Income

$

8,365,319

$

8,206,332

Net Interest Margin

3.85

%

3.86

%

Average Balance Sheet and Yields

For the Three Months Ended

June 30, 2026

June 30, 2025

Average
Balance

Interest

Average Yield/Rate

Average
Balance

Interest

Average Yield/Rate

Interest Earning Assets:

Federal funds sold

$

3,521,978

$

32,189

3.67

%

$

4,391,538

$

48,968

4.47

%

Deposits with banks

54,403,513

479,362

3.53

%

101,230,867

1,095,171

4.34

%

Investment securities

106,258,336

1,028,148

3.88

%

109,636,098

1,161,439

4.09

%

Loans

708,187,996

11,727,349

6.64

%

674,518,875

11,181,795

6.65

%

Total Interest Earning Assets

$

872,371,823

$

13,267,048

6.10

%

$

889,777,378

$

13,487,373

6.08

%

Non-Interest Earning Assets

$

41,795,279

$

40,031,708

Total Assets

$

914,167,102

$

929,809,086

Interest Bearing Liabilities:

Interest bearing demand

$

104,563,048

$

369,136

1.42

%

$

107,769,299

$

373,496

1.39

%

Savings and Money Market

347,058,899

2,835,039

3.28

%

296,161,664

2,497,634

3.38

%

Time deposits - Retail

155,333,571

1,335,594

3.45

%

211,751,684

2,123,642

4.02

%

Time Deposits - Wholesale

2,540,000

25,650

4.05

%

5,070,000

52,144

4.13

%

Total Interest Bearing Deposits

609,495,518

4,565,419

3.00

%

620,752,647

5,046,916

3.26

%

Total Borrowed Funds

27,307,385

336,310

4.94

%

27,430,238

344,231

4.96

%

Total Interest Bearing Liabilities

636,802,903

4,901,729

3.09

%

648,182,885

5,391,147

3.33

%

Non-Interest Bearing Deposits

162,926,161

-

0.00

%

178,549,677

-

0.00

%

Total Funding Sources/Cost

799,729,064

4,901,729

2.46

%

826,732,562

5,391,147

2.61

%

Non-Interest Bearing Liabilities

14,870,604

12,197,579

Equity

99,567,434

90,878,946

Total Liabilities and Equity

$

914,167,102

$

929,809,086

Net Interest Income

$

8,365,319

$

8,096,226

Net Interest Margin

3.85

%

3.66

%

Average Balance Sheet and Yields

For the Six Months Ended

June 30, 2026

June 30, 2025

Average
Balance

Interest

Average Yield/Rate

Average
Balance

Interest

Average Yield/Rate

Interest Earning Assets:

Federal funds sold

$

3,585,608

$

65,434

3.68

%

$

4,569,807

$

100,521

4.44

%

Deposits with banks

45,744,179

789,085

3.48

%

109,611,472

2,359,340

4.34

%

Investment securities

108,356,189

2,246,174

4.18

%

104,119,287

2,135,178

4.14

%

Loans

709,286,142

23,198,714

6.60

%

674,926,165

22,487,850

6.72

%

Total Interest Earning Assets

$

866,972,118

$

26,299,407

6.12

%

$

893,226,731

$

27,082,889

6.11

%

Non-Interest Earning Assets

$

41,607,280

$

40,010,655

Total Assets

$

908,579,398

$

933,237,386

Interest Bearing Liabilities:

Interest bearing demand

$

103,327,413

$

718,212

1.40

%

$

106,113,429

$

701,713

1.33

%

Savings and Money Market

337,565,023

5,474,561

3.27

%

289,896,939

4,886,018

3.40

%

Time deposits - Retail

160,495,362

2,804,481

3.52

%

221,669,292

4,569,911

4.16

%

Time Deposits - Wholesale

2,847,514

57,204

4.05

%

5,605,160

114,403

4.12

%

Total Interest Bearing Deposits

604,235,312

9,054,458

3.02

%

623,284,820

10,272,045

3.32

%

Total Borrowed Funds

27,297,635

673,299

4.97

%

27,569,740

694,276

5.08

%

Total Interest Bearing Liabilities

631,532,947

9,727,757

3.11

%

650,854,560

10,966,321

3.40

%

Non-Interest Bearing Deposits

164,382,753

-

0.00

%

181,029,672

-

0.00

%

Total Funding Sources/Cost

795,915,700

9,727,757

2.46

%

831,884,232

10,966,321

2.66

%

Non-Interest Bearing Liabilities

13,831,646

12,112,019

Equity

98,832,052

89,241,135

Total Liabilities and Equity

$

908,579,398

$

933,237,386

Net Interest Income

$

16,571,650

$

16,116,568

Net Interest Margin

3.85

%

3.65

%

Contact:
Kevin Vaughn
Chief Financial Officer
(623) 334-6064
[email protected]

SOURCE: Southwest Heritage Bank

Crescent Energy (CRGY - Free Report) reported $1.39 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 55.3%. EPS of $0.69 for the same period compares to $0.43 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.23 billion, representing a surprise of +13.21%. The company delivered an EPS surprise of +16.95%, with the consensus EPS estimate being $0.59.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Crescent Energy performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Average daily net sales volumes - Oil: 140 millions of barrels of oil per day versus the four-analyst average estimate of 135.66 millions of barrels of oil per day.Average daily net sales volumes - Natural Gas: 715 millions of cubic feet per day versus 733.08 millions of cubic feet per day estimated by four analysts on average.Average daily net sales volumes - Natural gas liquids: 76 millions of barrels of oil per day compared to the 73.03 millions of barrels of oil per day average estimate based on four analysts.Average daily net sales volumes - Total: 335 millions of barrels of oil equivalent per day compared to the 330.61 millions of barrels of oil equivalent per day average estimate based on four analysts.Average sales price per bbl - Oil (before effects of derivative settlements): $96.61 versus the three-analyst average estimate of $88.26.Average sales price per mcf - Natural gas (before effects of derivative settlements): $0.52 versus the three-analyst average estimate of $0.98.Average sales price per bbl - Natural gas liquids (before effects of derivative settlements): $18.67 versus the three-analyst average estimate of $20.56.Average realized prices per bbl - NGLs (after effects of derivative settlements): $18.67 compared to the $20.40 average estimate based on two analysts.Revenues- Natural gas liquids: $129.37 million versus the three-analyst average estimate of $136.86 million. The reported number represents a year-over-year change of +31.8%.Revenues- Oil: $1.23 billion compared to the $1.03 billion average estimate based on two analysts. The reported number represents a change of +103.6% year over year.Revenues- Midstream and other: $4.98 million compared to the $6 million average estimate based on two analysts. The reported number represents a change of -87% year over year.Revenues- Natural gas: $33.78 million versus the two-analyst average estimate of $87 million. The reported number represents a year-over-year change of -78.8%.View all Key Company Metrics for Crescent Energy here>>>

Shares of Crescent Energy have returned +22.8% over the past month versus the Zacks S&P 500 composite's +0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

SBA Communications Corporation (SBAC) Q2 2026 Earnings Call August 3, 2026 5:00 PM EDT

Company Participants

Louis Friend - Vice President of Capital Markets & Finance
Marc Montagner - Executive VP & CFO
Brendan Cavanagh - CEO, President & Director

Conference Call Participants

Batya Levi - UBS Investment Bank, Research Division
Ric Prentiss - Raymond James & Associates, Inc., Research Division
Michael Rollins - Citigroup Inc., Research Division
Jonathan Atkin - RBC Capital Markets, Research Division
Brendan Lynch - Barclays Bank PLC, Research Division
Richard Choe - JPMorgan Chase & Co, Research Division
Cameron McVeigh - Morgan Stanley, Research Division
Ryan Smyth - New Street Research LLP
Matthew Niknam - Truist Securities, Inc., Research Division
Eric Luebchow - Wells Fargo Securities, LLC, Research Division
Michael Ng - Goldman Sachs Group, Inc., Research Division
Nicholas Del Deo - MoffettNathanson LLC
Aryeh Klein - BMO Capital Markets Equity Research

Presentation

Operator

Welcome, and thank you all for joining today's SBA Second Quarter 2026 Results. Please note that today's call is being recorded. [Operator Instructions]

With that, I'd now like to formally begin today's call and turn it over to Louis Friend, Vice President of Finance and Capital Markets. Please go ahead.

Louis Friend
Vice President of Capital Markets & Finance

Good evening, and thank you for joining us for SBA's Second Quarter 2026 Earnings Conference Call. Here with me today are Brendan Cavanagh, our President and Chief Executive Officer; and Marc Montagner, our Chief Financial Officer.

Some of the information we will discuss on this call is forward-looking, including, but not limited to, any guidance for 2026 and beyond. In today's press release and in our SEC filings, we detail material risks that may cause our future results to differ from our expectations. Our statements are as of today, August 3, and we have no obligation to update any forward-looking statements we may make.

Dorman Products (DORM - Free Report) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $2.06 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +73.03%. A quarter ago, it was expected that this distributor of parts to automotive retailers would post earnings of $1.52 per share when it actually produced earnings of $1.57, delivering a surprise of +3.29%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Dorman Products, which belongs to the Zacks Automotive - Replacement Parts industry, posted revenues of $544.6 million for the quarter ended June 2026, missing the Zacks Consensus Estimate by 6.41%. This compares to year-ago revenues of $540.96 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Dorman Products shares have added about 8.1% since the beginning of the year versus the S&P 500's gain of 9.4%.

What's Next for Dorman Products?While Dorman Products has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Dorman Products was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.44 on $584.33 million in revenues for the coming quarter and $8.22 on $2.29 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Automotive - Replacement Parts is currently in the bottom 12% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the broader Zacks Auto-Tires-Trucks sector, Atmus Filtration Technologies (ATMU - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 7.

This industrial filtration product company is expected to post quarterly earnings of $0.79 per share in its upcoming report, which represents a year-over-year change of +5.3%. The consensus EPS estimate for the quarter has been revised 0.7% higher over the last 30 days to the current level.

Atmus Filtration Technologies' revenues are expected to be $510.5 million, up 12.6% from the year-ago quarter.

The July 23 spike — worth about $57 million in ETH — was driven largely by the Drift exploiter, who pushed $44 million through the mixer in under two hours.

Tornado Cash processed 968 deposits on July 23, its busiest day of 2026, according to L2Beat data.

The spike shows large-scale attackers have returned to the privacy protocol since the U.S. Treasury lifted sanctions in March 2025 — and that its baseline usage keeps climbing even as developer Roman Storm awaits a retrial over operating it.

Depositors moved 29,573 ETH, worth about $57.2 million at July 23 prices, into the mixer's Ethereum pools that day across 110 addresses, per onchain data. Most of it came from one: the address labeled Drift Exploiter 4 made 245 deposits totaling 23,095 ETH, about $44.4 million and 78% of the day's inflow, in under two hours.

"The Drift Protocol exploiter who stole $285M has deposited 23,095 $ETH ($44.4M) into #TornadoCash today," onchain tracker Lookonchain wrote on X on July 24. "The exploiter still holds 107,165 $ETH ($201M)."

Security firm PeckShield posted the same figures, noting the exploiter also sent 0.85 ETH to Bybit.

Drift Money on the MoveThe deposits were the first movement of funds from the April 1 exploit of Drift, the Solana perps DEX drained of roughly $285 million in the largest DeFi hack of 2026. Blockchain forensics firms including TRM Labs and Elliptic have attributed the attack with medium-to-high confidence to UNC4736, the North Korea-linked cluster behind the $1.5 billion Bybit hack.

Even setting the exploiter aside, the day's remaining 723 deposits from 109 other addresses exceeded most full days in 2025, when July 23 of that year saw 177 deposits total.

Post-Delisting ReboundTornado Cash usage has rebounded steadily since Treasury's Office of Foreign Assets Control delisted it in March 2025, following a Fifth Circuit ruling that immutable smart contracts can't be sanctioned. The mixer has captured more than 20% of crypto mixing volume in 2026, with weekly inflows of $10 million to $80 million, according to TRM Labs — up from about 16% in the years after the 2022 sanctions. The 2026 peak still trails Nov. 5, 2025, when Richard Heart-linked wallets helped drive 1,363 deposits in a day.

Storm's case continues alongside the rebound. Prosecutors are seeking an October retrial of Storm on money-laundering and sanctions-conspiracy charges after a Manhattan jury hung on those counts in August 2025, while Judge Katherine Polk Failla weighs his acquittal bid on the single count where jurors convicted.

Open Compute Project Specification provides foundation for High Bandwidth Flash adoption in AI inference systems

MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (Nasdaq: SNDK) and SK hynix Inc. today announced the release of the HBF™ (High Bandwidth Flash) technical specification through the Open Compute Project (OCP), advancing the workstream to drive HBF standardization for the AI inference era, just six months after the consortium began work in February.

The specification was developed through the HBF technology workstream under OCP, with Sandisk and SK hynix serving as primary contributors. Notably, Google and Tenstorrent joined as consortium members during this standardization process, contributing significantly to technology validation and the establishment of the standard. The specification provides companies and developers designing AI inference systems and accelerators with a common technical framework for incorporating HBF technology where larger, near-compute memory capacity and higher bandwidth are needed to improve power and performance metrics and help reduce total cost of ownership.

Modern AI inference systems need high-bandwidth memory positioned close to compute cores, while the demand for greater near-compute memory capacity continues to grow with the requirements of large language models and emerging AI workloads. HBF technology is designed to address this need by combining high bandwidth with high capacity, helping data center system designers improve interactivity and throughput during model serving.

“AI inference is creating a new set of memory requirements, and HBF technology is designed to meet that moment,” said Alper Ilkbahar, Chief Technology Officer, Sandisk. “This specification helps give system designers a practical path to bring high-capacity, high-bandwidth memory closer to compute, while enabling more flexible architectures. It is an important milestone for the HBF ecosystem and for the next generation of AI systems built to improve token economics at scale.”

The specification defines system interface, electrical and other technical guidelines for designing systems that interact with and use HBF technology, including basic performance expectations, the xPU-HBF host interface, reliability and packaging guidance for an HBF die stack, and a software user guide for read and write operations. As one of the first technical standards of its kind in the memory and storage industry, the specification helps give AI compute system designers added flexibility to build systems where HBF technology can coexist with High Bandwidth Memory, helping support ecosystem readiness.

The specification was released within the Open Compute Project framework, meaning the information is openly available to the industry. Sandisk and SK hynix proactively published the specification to position HBF technology as the de facto standard in the rapidly evolving AI storage market. Their strategy involves fostering an early-stage ecosystem, increasing the visibility of HBF technology’s adoption for customers, and accelerating market expansion and technological maturity through open collaboration and membership in the consortium.

Sandisk Keynote: NAND - The Versatile & Scalable Foundation of the AI Era

On Wednesday, August 5, at 11:40 a.m. PT, Sandisk’s keynote at The Future of Memory and Storage Conference (FMS) at the Santa Clara Convention Center will explore the importance of system-level optimization and NAND in enabling AI inference at scale. The keynote will feature Sandisk’s Jim Elliott, chief revenue officer; Khurram Ismail, chief product officer; and Alper Ilkbahar, chief technology officer.

FMS Panel Discussion: Breaking the Memory Wall with High Bandwidth Flash

On Thursday, August 6, at 9:45 a.m. PT, Sandisk, SK hynix, and Google will present a panel discussion hosted by Thomas Coughlin, President of Coughlin Associates, at The Future of Memory and Storage Conference (FMS) at the Santa Clara Convention Center, Conference Room D. The session will discuss how HBF technology aims to redefine the memory hierarchy by providing near-memory speeds with the density and persistence of high bandwidth flash. The panel will bring together experts from HBF solution providers as well as a Hyperscale-AI Infrastructure provider, to dissect the HBF technology usage and development needed for success, including Architectural Integration, Technical Challenges, Standardization timelines, performance and economics.

About Sandisk

Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, YouTube. Join TeamSandisk on Instagram.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of U.S. federal securities laws, including, among others, statements regarding expectations for: the advancement of HBF standardization with the release of the first OCP technical specification; the impact of the HBF technical specification on HBF adoption in AI inference systems; and the capabilities, benefits and industry impact of HBF technology. These forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.

Key risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements include: adverse changes in global or regional economic conditions, including the impact of evolving trade policies, tariff regimes and trade wars; volatility in demand for Sandisk’s products; pricing trends and fluctuations in average selling prices; exposure to execution, financial and market risks due to long-term agreements; inflation; changes in interest rates and a potential economic recession; the impact of business and market conditions; the impact of competitive products and pricing; the development and introduction of products based on new technologies and management of technology transitions; risks associated with strategic initiatives, including restructurings, acquisitions, divestitures, cost saving measures and joint ventures; risks related to product defects; difficulties or delays in manufacturing or other supply chain disruptions; reliance on strategic relationships with key partners, including Kioxia Corporation; the attraction, retention and development of skilled management and technical talent; risks associated with the use of artificial intelligence in business operations; changes to relationships with key customers or consolidation among the customer base; compromise, damage or interruption from cybersecurity incidents or other data system security risks; reliance on intellectual property; fluctuations in currency exchange rates; actions by competitors; risks associated with compliance with changing legal and regulatory requirements; and other risks and uncertainties listed in Sandisk’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K filed with the SEC on August 21, 2025 and Quarterly Report on Form 10-Q filed with the SEC on May 1, 2026, to which your attention is directed. You should not place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Sandisk undertakes no obligation to update or revise these forward-looking statements to reflect new information or events, except as required by law.

© 2026 Sandisk Corporation or its affiliates. All rights reserved.

SANDISK, the SANDISK logo and HBF are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the U.S. and/or other countries. All other marks are the property of their respective owners.

5 High-Yield Stocks That Could Help Cushion Market VolatilityClorox NYSE: CLX said it is entering fiscal 2027 with improving market-share trends, a completed enterprise resource planning implementation and a plan to offset more than $200 million in expected supply-chain inflation through productivity initiatives and targeted pricing.

Chair and CEO Linda Rendle said the company operated through fiscal 2026 in an environment marked by value-seeking consumers, heightened competition, inflation and macroeconomic uncertainty. Clorox has responded by adjusting product offerings, price-pack architecture, promotions, brand investment and distribution, while continuing its broader operational transformation.

Get Clorox alerts:

3 Defensive Stocks to Buy as Economic Uncertainty Lingers“While the majority of our businesses are performing at or above expectations, we have taken decisive actions to improve in the areas that are not yet delivering what we expect,” Rendle said. She said the company saw sequential improvement in consumption and market share during fiscal 2026, with consumption returning to flat in the fourth quarter and aggregate share down only one-tenth of a percentage point.

Fiscal 2027 outlook includes muted category growth Rendle said Clorox expects category growth to remain muted in fiscal 2027, broadly consistent with fiscal 2026, as consumers continue seeking value. The company’s outlook assumes continuity in category conditions and does not contemplate significant disruption from inflation or geopolitical developments.

3 Dividend Stocks Raising Payouts—and Backing It Up With ResultsClorox expects organic sales to be flat to slightly higher for the year, with a slower first quarter primarily due to timing effects in Kingsford grilling products and promotions. Rendle described the first-quarter impact as a “blip,” saying the rest of the year, particularly the back half, should more closely resemble fiscal 2026 trends.

Kingsford faced a difficult grilling season as weather affected key holidays. Rendle said Memorial Day was unusually cool and wet across much of the U.S., while widespread heat advisories during the July 4 weekend discouraged grilling. Retailers also emphasized smaller sizes on promotion to appeal to value-oriented shoppers. Clorox plans to adjust its merchandising approach next season by encouraging earlier seasonal purchases.

Management expects to continue improving market share in fiscal 2027. Rendle highlighted eight consecutive quarters of share growth in home care, as well as continued share gains in professional and international businesses. The company also cited improving results in Glad and Hidden Valley Ranch, while identifying litter and Kingsford as areas where further progress is needed.

Inflation, pricing and margins CFO Luc Bellet said Clorox expects fiscal 2027 inflation of more than $200 million, more than double the company’s historical range of $75 million to $100 million. The outlook assumes Brent crude oil averages about $90 a barrel and includes cost pressures beyond commodities, including supplier costs, ocean freight, trucking and other logistics expenses.

Bellet said inflation is expected to be more pronounced in the first half of the fiscal year. Productivity will be the company’s primary offset, supplemented by selective pricing and other revenue-management actions. Clorox expects to begin recovering gross margin in the second half, although it does not expect to fully recover margin for the full year. The company expects to exit fiscal 2027 with a stronger gross margin.

Rendle said Clorox is taking a more selective approach to pricing than in prior inflationary periods, following several substantial price increases during 2022 and 2023. The company is implementing a regular price increase in Glad trash because of that category’s resin exposure, while using targeted pricing elsewhere in the portfolio.

“Pricing is only one tool in the toolbox,” Rendle said, pointing to revenue growth management, price-pack architecture, cost savings and innovation as additional levers. She said management does not see a structural loss of pricing power in its categories, but views the current environment as unusual because it follows back-to-back inflation cycles and pressure on consumer budgets.

GOJO acquisition and operating transformation Management said the integration of GOJO, which brings the Purell brand into Clorox’s portfolio, is proceeding as planned and in some areas ahead of plan. Rendle said the business performed ahead of its fourth-quarter targets, while Bellet said GOJO was accretive rather than dilutive to adjusted earnings per share in the quarter.

Bellet said GOJO is expected to be accretive to adjusted EPS in fiscal 2027 and is expected to grow at a mid-single-digit rate before potential revenue synergies. As those synergies are realized, management expects growth in the business could reach the mid- to high-single digits for several years.

The CFO also noted that GOJO’s business-to-business model has a different profit-and-loss profile than Clorox’s legacy operations, including lower advertising spending as a percentage of sales and higher selling, general and administrative expenses.

Clorox completed its ERP implementation and is now focused on stabilizing and optimizing the system. Bellet said the company expects supply-chain and administrative benefits to build later in fiscal 2027 and into the following year. Potential benefits include improved planning, lower inventory, automation, more responsive demand fulfillment and increased use of global business services.

Litter turnaround and CEO search Rendle said litter remains the company’s principal work in progress following the cyberattack and operational disruptions of prior years. The company has restored lost distribution, but is continuing to overhaul the Fresh Step brand through product improvements, packaging changes, marketing, e-commerce upgrades and targeted pricing.

Clorox reduced dust in certain Fresh Step products, expanded investment in lightweight litter and changed packaging and marketing. Rendle said more innovation is planned for the back half of fiscal 2027, though she cautioned that rebuilding consumer awareness, repeat purchases and category momentum will take time.

Rendle also provided an update on Clorox’s CEO succession process. She previously informed the board of her intention to step down due to personal health challenges. She said she is cancer-free, feels well and remains focused on running the company. The board has hired an external search firm and the process is progressing according to its expected timeline.

Clorox expects fiscal 2027 free cash flow to remain within its targeted range of 11% to 13% of sales. Bellet said the company remains committed to its dividend, describing the currently elevated payout ratio as transitory while gross margins rebuild.

About Clorox (NYSE:CLX)The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Clorox Right Now?Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Williams Companies, Inc. (The) (WMB - Free Report) came out with quarterly earnings of $0.5 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.46 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -3.85%. A quarter ago, it was expected that this pipeline operator would post earnings of $0.65 per share when it actually produced earnings of $0.73, delivering a surprise of +12.31%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

The Williams Companies, which belongs to the Zacks Oil and Gas - Production and Pipelines industry, posted revenues of $3.05 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 1%. This compares to year-ago revenues of $2.78 billion. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

The Williams Companies shares have added about 19% since the beginning of the year versus the S&P 500's gain of 9.4%.

What's Next for The Williams Companies?While The Williams Companies has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for The Williams Companies was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.56 on $3.19 billion in revenues for the coming quarter and $2.35 on $12.82 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Production and Pipelines is currently in the bottom 26% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

South Bow Corporation (SOBO - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.

This company is expected to post quarterly earnings of $0.45 per share in its upcoming report, which represents a year-over-year change of +7.1%. The consensus EPS estimate for the quarter has been revised 0.6% lower over the last 30 days to the current level.

South Bow Corporation's revenues are expected to be $516.13 million, down 1.5% from the year-ago quarter.

AI’s Power Problem Is Turning Nuclear Stocks Into a Bigger Market StoryBWX Technologies NYSE: BWXT reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets.

Second-quarter revenue reached $902 million, including 9% organic growth, while adjusted EBITDA rose 7% to $156 million. Adjusted earnings per share increased 5% to $1.70, and free cash flow totaled $115 million. The company ended the quarter with $8.4 billion in backlog, up 40% from a year earlier, and reported a trailing 12-month book-to-bill ratio of 1.7 times.

Get BWX Technologies alerts:

3 Overlooked Nuclear Fuel Supply Chain WinnersPresident and CEO Rex Geveden said the company sees the nuclear industry in the early stages of a “multi-decade super cycle of growth,” supported by demand for naval propulsion, national security programs, commercial reactor equipment and nuclear services.

Medical Business Sale and PCG Acquisition BWXT announced the sale of just over 80% of its medical business and Kinectrics stable-isotope enrichment operations to Nordic Capital in a transaction valued at up to $800 million. The deal includes $750 million of consideration, with shared economics that could lift the value to $800 million, according to Senior Vice President and CFO Mike Fitzgerald.

Nuclear's Pullback: A Generational Buying Opportunity?BWXT will retain a 20% equity interest in the businesses and will continue providing certain specialty manufacturing services after the transaction closes. The sale excludes the company’s Isogen joint venture with Framatome, which provides irradiation services through Bruce Power.

Geveden said the medical operations represented about 3% of BWXT’s total sales but required a disproportionate amount of management attention. He said the transaction would allow the company to concentrate resources on nuclear national security and commercial power opportunities while placing the medical assets with an owner focused on the healthcare market.

Fitzgerald said the businesses being sold are expected to account for approximately $130 million of 2026 revenue at a margin modestly above the Commercial Operations segment average. After the sale, BWXT will account for its retained interest through equity income rather than revenue.

The company also completed its acquisition of Precision Components Group, or PCG, in early July. While much of PCG’s current work is tied to the U.S. Naval Nuclear Propulsion Program, Geveden said the business adds commercial nuclear manufacturing capabilities, including experience supporting AP1000 components.

BWXT is assessing how to deploy capital at PCG and evaluating additional U.S. commercial manufacturing expansion. Potential sites include Mount Vernon, Indiana, as well as East Coast locations that could leverage PCG’s real estate and workforce. The company said it needs deep-water port access to serve global markets for large equipment, such as steam generators and reactor pressure vessels. BWXT received a $21 million Department of Energy award in May to support domestic manufacturing capacity expansion and expects a final investment decision in coming months.

Commercial Nuclear Pipeline Expands Commercial Operations revenue increased 72% in the quarter, including 33% organic growth. Adjusted EBITDA in the segment more than doubled to $36 million, while adjusted EBITDA margin was 11.9%. Results reflected higher Canadian field services and aftermarket work, nuclear medicine growth, and increased Kinectrics revenue.

Geveden said BWXT is pursuing work with multiple reactor vendors globally and sees a credible opportunity to secure at least one new-build nuclear equipment order before the end of 2026. He pointed to opportunities involving small modular reactors, AP1000 projects and GE Vernova’s BWRX-300 technology.

Canada’s recently released nuclear strategy was also cited as a potential source of future demand. The plan contemplates up to 10 new large reactors over coming decades, in addition to SMR deployments and CANDU life-extension programs. Geveden said long-lead equipment orders for large Canadian projects could begin to affect BWXT’s business positively in the early 2030s.

The company is also pursuing arrangements to monetize its mPower small modular reactor intellectual property. BWXT signed an exclusive land-based licensing agreement with Applied Atomics, which will lead and fund completion of the design and licensing process. BWXT will support that work, retain the intellectual property and hold exclusive manufacturing and royalty rights. Separately, BWXT is conducting a feasibility study with Core Power on using mPower technology for floating nuclear platforms serving offshore energy markets.

Government Operations and Advanced Nuclear Programs Government Operations revenue grew 2% during the quarter as growth in Special Materials and naval propulsion offset lower microreactor volumes. Segment adjusted EBITDA was $126 million, representing a 20.9% margin.

BWXT said its Defense Fuels Enrichment and High Purity Depleted Uranium programs are progressing. The company expects to deliver an operational prototype centrifuge this year at its centrifuge manufacturing development facility, while engineering and site preparation continue for new HPDU plants in Jonesborough, Tennessee.

Geveden also highlighted the Navy’s updated 30-year shipbuilding plan, which calls for sustained annual production of two Virginia-class submarines and one Columbia-class submarine, while accelerating Ford-class aircraft carrier procurement to a four-year cadence. He said the faster Ford cadence should improve manufacturing stability by reducing periods in which only one ship set is moving through BWXT’s plants.

The plan additionally introduces a nuclear-powered battleship concept using one Ford-class reactor. Geveden said the initiative remains in its early stages and is dependent on further authorization and appropriations, but long-lead procurement could begin in 2028 if the program moves forward.

Raised 2026 Outlook BWXT raised full-year free cash flow guidance by $30 million to a range of $345 million to $360 million. It now expects approximately $3.8 billion of revenue for 2026, representing high-teens growth from 2025, and increased adjusted EBITDA guidance to $662 million to $672 million.

Government Operations revenue growth is now expected in the high single digits, down from a prior low-teens expectation, reflecting better cost performance that reduces reported revenue under the company’s accounting rules. Government Operations adjusted EBITDA margin guidance rose to approximately 20.5%, from greater than 19% previously. Commercial Operations revenue growth guidance increased to approximately 45%, from approximately 30%, with slightly more than half of the increase attributed to PCG and the remainder driven by commercial power growth and improved Kinectrics performance. Commercial Operations adjusted EBITDA margin guidance was lowered to approximately 13% from approximately 14%, reflecting investments in U.S. and Canadian capacity. Non-GAAP earnings-per-share guidance was raised to $4.70 to $4.80, with the increase driven entirely by stronger operating earnings. Fitzgerald said BWXT expects about 55% of second-half earnings to be generated in the fourth quarter because of normal Commercial Operations seasonality and the timing of Government Operations program ramps.

About BWX Technologies (NYSE:BWXT)BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in BWX Technologies Right Now?Before you consider BWX Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BWX Technologies wasn't on the list.

While BWX Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Inspire Medical Systems (INSP - Free Report) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +163.64%. A quarter ago, it was expected that this maker of devices for treating obstructive sleep apnea would post a loss of $0.36 per share when it actually produced earnings of $0.1, delivering a surprise of +127.78%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Inspire, which belongs to the Zacks Medical Info Systems industry, posted revenues of $200.58 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.95%. This compares to year-ago revenues of $217.09 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Inspire shares have lost about 45.6% since the beginning of the year versus the S&P 500's gain of 9.4%.

What's Next for Inspire?While Inspire has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Inspire was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.21 on $203.81 million in revenues for the coming quarter and $0.93 on $844.21 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Info Systems is currently in the top 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Privia Health (PRVA - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.

This physician practice management company is expected to post quarterly earnings of $0.08 per share in its upcoming report, which represents a year-over-year change of +300%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Privia Health's revenues are expected to be $581.67 million, up 11.6% from the year-ago quarter.

SAN JOSE, Calif, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Residents along Harrison Road at Avenue 266 now have safe, clean, reliable drinking water for their everyday and emergency needs, thanks to a partnership among California Water Service (Cal Water), the County of Tulare, the State of California’s Department of Water Resources (DWR), and Self-Help Enterprises.

This project extended Cal Water’s water main to connect 27 customers whose wells had gone dry. More than $1.3 million in funding was secured for the project through a direct allocation of the County’s American Recovery Plan Act (ARPA) funding and DWR’s Small Community Drought Relief Program to the County of Tulare. With the grant, crews installed 2,265 feet of 8-inch pipe and 335 feet of 12-inch pipe to connect the underserved community to Cal Water’s Visalia District. Five fire hydrants were also installed to improve fire protection in the area.

“We believe that everyone should have access to safe, clean, reliable water, yet we know that’s not a reality for too many communities right here in California,” said Marty Kropelnicki, Cal Water Chairman and CEO. “We are pleased that, through this partnership with Tulare County, DWR, and Self-Help Enterprises, residents along Harrison Road can now have the dependable supply of safe, reliable water they need.”

The County of Tulare committed significant ARPA funding to address long-standing drinking water challenges in its communities. “This project was denied previous drought funding, and households have continued to receive hauled and bottled water for several years,” said Pete Vander Poel, County of Tulare District 2 Supervisor. “The County leveraged ARPA funds against new drought funding provided by DWR. This project is a prime example of state and local government working together to improve access to clean, affordable drinking water for communities that need it most.”

“DWR believes every community should have access to reliable water for drinking, irrigating, emergency, and recreation,” said Sammy Naventhan, DWR Small Community Drought Relief Program Manager. “The resilience this community and our partners have shown on this project showcases what’s possible when human right to water is at the forefront in an underserved region. DWR is proud to have worked with Self-Help Enterprises, the County of Tulare, and Cal Water to make this happen.”

About California Water Service

California Water Service provides high-quality, reliable water utility services to more than 2 million people statewide through 500,000 service connections. Cal Water’s purpose is to enhance the quality of life for customers and communities. To do so, it invests responsibly in water and wastewater infrastructure, sustainability initiatives, and community well-being. The company’s 1,200 employees live by a set of strong core values and share a commitment to protecting the planet, caring for people, and operating with the utmost integrity.  The company, commemorating a century of service this year, has been named one of “America’s Most Responsible Companies” and one of the “World’s Most Trustworthy Companies” by Newsweek, a USA Top Workplace, and a Great Place to Work®.  More information is available at www.calwater.com.

Contact: Yvonne Kingman, (310) 257-1434

Vertex’s Crinetics Deal Balances Growth with Integration RiskVertex Pharmaceuticals NASDAQ: VRTX reported second-quarter 2026 revenue growth of 12% year over year to $3.3 billion, driven by continued growth in its cystic fibrosis franchise and rising contributions from newer products CASGEVY and JOURNAVX.

Chief Executive Officer and President Reshma Kewalramani said the company made progress across commercial operations, clinical development and regulatory activities during the quarter. Vertex raised its full-year revenue guidance to $13.1 billion to $13.2 billion, while maintaining its expectation that non-cystic-fibrosis products will generate at least $500 million in 2026 revenue.

Get Vertex Pharmaceuticals alerts:

Cystic Fibrosis Franchise Continues to Expand CRISPR Therapeutics Gains After Earnings as Pipeline Hope GrowsGlobal cystic fibrosis revenue increased 11% from a year earlier, supported by uptake of ALYFTREK and continued performance from TRIKAFTA. Chief Commercial Officer Duncan McKechnie said ALYFTREK surpassed $1 billion in revenue during the first half of 2026.

In the U.S., ALYFTREK growth included patients new to therapy, patients returning to therapy and patients switching from TRIKAFTA. McKechnie said most ALYFTREK revenue continued to come from patients switching from TRIKAFTA. In Germany and the United Kingdom, more than one-third of eligible cystic fibrosis patients are now using ALYFTREK, according to the company.

How Royalty Pharma Prints Cash Without Biotech's Biggest RisksVertex has initiated global regulatory submissions for ALYFTREK in children ages 2 to 5 and is progressing submissions for TRIKAFTA in patients ages 1 to 2. The company expects data in the second half of 2026 from VX-828, its next-generation 3.0 CFTR modulator. Kewalramani said Vertex will advance future CF candidates only if they show potential to surpass ALYFTREK on measures including the number of patients reaching sweat chloride levels below 30 millimoles per liter, along with once-daily dosing and favorable drug-interaction properties.

CASGEVY and JOURNAVX Gain Momentum CASGEVY generated $76 million in second-quarter revenue, representing approximately 75% sequential growth and more than 150% growth from the prior year, McKechnie said. The company reported more CASGEVY infusions in the first half of 2026 than in all of 2025 and said the second quarter marked the third consecutive quarter with more than 100 patient initiations.

The FDA approved CASGEVY for children as young as 2 with sickle cell disease and beta thalassemia last month. Vertex said the approval came 53 days after filing and that its first pediatric patient had initiated therapy and completed cell collection. The company also cited reimbursement progress in Germany, the United Kingdom, Italy and the Middle East.

JOURNAVX, Vertex’s treatment for moderate-to-severe acute pain, recorded $50 million in second-quarter revenue, up about 70% sequentially. Prescriptions rose approximately 45% sequentially to roughly 535,000 in the quarter, bringing first-half prescriptions to more than 900,000.

McKechnie said revenue benefited from channel inventory build following a first-quarter drawdown, adding that quarterly revenue may remain affected by wholesaler and retail buying patterns. The company said JOURNAVX is now included on about 1,400 hospital pathways and 130 integrated delivery network pathways. Vertex added approximately 18,000 healthcare professional prescribers during the quarter.

JOURNAVX has coverage for approximately 260 million of a potential 320 million lives, including 180 million lives with unrestricted access, Vertex said. The company expects gross-to-net deductions to normalize in the first half of 2027 as physician education and payer access improve.

Renal Pipeline and Povi Launch Preparation Vertex is preparing for a potential U.S. launch of povetacicept, or Povi, in immunoglobulin A nephropathy. The FDA accepted the biologics license application and set a Nov. 30 PDUFA date. Kewalramani said the company plans to present the full interim data set from the RAINIER Phase III trial at a fall medical conference.

Vertex has completed hiring its renal field force, with about 90% of representatives having nephrology experience, according to McKechnie. The company expects Povi to compete based on its efficacy profile, tolerability and once-monthly, low-volume at-home autoinjector administration.

In primary membranous nephropathy, the independent data monitoring committee selected an 80-milligram subcutaneous dose administered every four weeks for the Phase III portion of the OLYMPUS study. Vertex said the committee based the decision on efficacy data involving PLA2R, a disease biomarker, and safety data.

Vertex also expects results this fall from the AMPLIFIED Phase II basket study of inaxaplin in expanded populations with APOL1-mediated kidney disease. Enrollment in the pivotal AMPLITUDE study is expected to finish by year-end, with an interim analysis planned for early 2027. The company said the potential accelerated-approval filing pathway for AMPLITUDE would be based on the one-year estimated glomerular filtration rate endpoint.

Diabetes Program and Crinetics Deal Vertex resumed dosing in its zimislecel Phase I/II/III type 1 diabetes study following a voluntary pause for manufacturing analysis. The FDA also cleared the investigational new drug application for VX-017, a type O, or universal-donor, islet-cell therapy designed for patients of all blood types.

Kewalramani said VX-017 could expand the addressable market from about 60,000 to about 120,000 patients in the U.S. and Europe. Vertex expects to begin the VX-017 Phase I/II study in the near term and plans to provide updated type 1 diabetes development and commercialization plans later this year.

The company also expects its acquisition of Crinetics Pharmaceuticals to close in the third quarter. Vertex agreed to acquire Crinetics for approximately $8.8 billion net of cash acquired and expects to fund the transaction through cash and a $4.5 billion term loan. Vertex said the transaction is expected to become accretive to non-GAAP operating income in 2029 and would establish rare endocrine diseases as its fifth commercial pillar.

Chief Operating Officer and Chief Financial Officer Charles Wagner said Vertex ended the quarter with approximately $13.6 billion in cash and investments. Second-quarter non-GAAP earnings per share rose 5% year over year to $4.73. The company reiterated combined non-GAAP operating expense guidance of $5.65 billion to $5.75 billion, while now expecting to land at the high end of that range.

About Vertex Pharmaceuticals (NASDAQ:VRTX)Vertex Pharmaceuticals Inc is a Boston-based biotechnology company focused on the discovery, development and commercialization of therapies for serious diseases. Founded in 1989, Vertex built its reputation on research-driven drug development and is best known for its work in cystic fibrosis (CF), where its portfolio of small-molecule CFTR modulators transformed standards of care for many people with the disease. The company operates research and development, manufacturing and commercial organizations and serves patients and healthcare systems in multiple international markets.

Vertex's marketed products center on CFTR modulators that target the underlying cause of cystic fibrosis rather than just treating symptoms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Vertex Pharmaceuticals Right Now?Before you consider Vertex Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vertex Pharmaceuticals wasn't on the list.

While Vertex Pharmaceuticals currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

CRISPR Therapeutics AG (CRSP - Free Report) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $1.1. This compares to a loss of $1.29 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +14.55%. A quarter ago, it was expected that this company would post a loss of $1.14 per share when it actually produced a loss of $1.28, delivering a surprise of -12.28%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

CRISPR Therapeutics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $10.18 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 37.28%. This compares to year-ago revenues of $0.89 million. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

CRISPR Therapeutics shares have lost about 8.5% since the beginning of the year versus the S&P 500's gain of 9.4%.

What's Next for CRISPR Therapeutics?While CRISPR Therapeutics has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for CRISPR Therapeutics was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$1.19 on $7.93 million in revenues for the coming quarter and -$4.90 on $28.88 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, CAMP4 Therapeutics Corporation (CAMP - Free Report) , is yet to report results for the quarter ended June 2026.

This company is expected to post quarterly loss of $0.24 per share in its upcoming report, which represents a year-over-year change of +61.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

CAMP4 Therapeutics Corporation's revenues are expected to be $1.35 million, down 10% from the year-ago quarter.

New Jersey Resources (NJR - Free Report) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +83.33%. A quarter ago, it was expected that this energy services holding company would post earnings of $1.89 per share when it actually produced earnings of $2.2, delivering a surprise of +16.4%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

New Jersey Resources, which belongs to the Zacks Utility - Gas Distribution industry, posted revenues of $349.18 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 4.27%. This compares to year-ago revenues of $298.95 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

New Jersey Resources shares have added about 25.5% since the beginning of the year versus the S&P 500's gain of 9.4%.

What's Next for New Jersey Resources?While New Jersey Resources has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for New Jersey Resources was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.16 on $379.41 million in revenues for the coming quarter and $3.58 on $2.24 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Gas Distribution is currently in the bottom 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, UGI (UGI - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.

This natural gas and electric utilities operator. is expected to post quarterly loss of $0.35 per share in its upcoming report, which represents a year-over-year change of -3400%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

UGI's revenues are expected to be $1.55 billion, up 11.1% from the year-ago quarter.

SBA Communications NASDAQ: SBAC reported second-quarter results in line with its expectations and modestly increased its full-year 2026 outlook for site leasing revenue, funds from operations (FFO) and FFO per share, citing higher straight-line revenue and improved net cash interest expense.

Chief Financial Officer Marc Montagner said second-quarter FFO per share was $3.05. The company paid a quarterly cash dividend of $1.25 per share and declared another $1.25-per-share dividend payable Sept. 17 to shareholders of record as of Aug. 20. The declared dividend is about 13% higher than the dividend paid in the prior-year period, according to Montagner.

Get SBA Communications alerts:

“We had another good quarter, and our results were in line with our expectation,” Montagner said. SBA said its companywide Tower Cash Flow margin was just under 80% during the quarter.

Leasing Activity Remains Steady In the U.S., SBA added about $9 million of new lease and amendment billings during the second quarter, with most activity coming from new co-locations as carriers densified networks and expanded coverage. Internationally, the company added about $4 million of new lease and amendment billings.

President and Chief Executive Officer Brendan Cavanagh said U.S. application volumes entering the second half remained relatively consistent with the first half of the year. One customer was more active than the others, though he said changing levels of activity among carriers were not unusual.

The company expects U.S. new-leasing contributions to be lower in the second half than in the first half, consistent with its prior outlook. Cavanagh said the company had not changed that expectation.

International demand remained healthy, though churn continued to be elevated because of carrier consolidations, bankruptcies, restructurings and network rationalizations. Cavanagh said SBA is working with customers on longer-term arrangements intended to provide more stable and predictable cash flow, sometimes involving rental relief in exchange for greater contractual certainty.

SBA expects it is nearing the end of its period of heightened international churn, though Cavanagh declined to provide a specific outlook for next year while discussions with customers continue.

Investment-Grade Debt Offering Reshapes Capital Structure In July, SBA issued $3.5 billion of unsecured investment-grade bonds, its first such offering. The company used net proceeds to fully repay its Term Loan B and outstanding balances under its revolving credit facility. As of the call, SBA’s revolver was fully paid down and it had about $570 million in cash.

The offering included:

$1.35 billion of notes due in 2030 with a 4.78% cash coupon; $1.35 billion of notes due in 2031 with a 5.15% cash coupon; and $800 million of notes due in 2033 with a 5.45% cash coupon. The bonds had a blended cash coupon of 5.11% and a weighted average maturity of five years. SBA also established a new unsecured revolving credit facility with $2.5 billion of capacity.

Montagner said secured debt now represents less than 50% of the company’s debt following the transaction. SBA ended the quarter with approximately $13 billion in total debt and net debt-to-adjusted EBITDA leverage of 6.4 times, within its target range of 6 to 7 times. In June, S&P upgraded SBA’s credit rating to BBB from BBB-.

The company continues to assume that its $1.2 billion asset-backed securities maturity in November will be refinanced at a 5.25% rate. While SBA expects to benefit from its investment-grade status, Cavanagh noted that some debt being refinanced had lower rates than current market borrowing costs.

Buybacks Take Priority Over Higher-Valued Acquisitions Cavanagh said SBA intends to resume share repurchases in the second half of 2026 after completing its July refinancing. He said management views buybacks as the best use of capital at current valuation levels and characterized the company’s shares as trading below what management believes is their intrinsic value.

The company will continue building towers and considering acquisitions, but Cavanagh said the limited supply of U.S. assets available for purchase generally carries valuations substantially higher than SBA’s own valuation. As a result, he said repurchasing shares is currently more attractive than pursuing acquisitions that could be dilutive.

SBA expects to build roughly 600 new towers during 2026, primarily in Central America, with a meaningful number also planned in Tanzania. The company built 99 towers in the second quarter, up from 75 in the first quarter. Cavanagh said construction activity should rise in each successive quarter through the rest of the year.

New tower construction has offered stronger returns internationally than in the U.S., where competition has at times compressed potential returns, according to Cavanagh. He said SBA sees opportunities in Africa and Central America and expects risk-adjusted returns on international builds to exceed its cost of capital, often beginning on the first day of operation.

Spectrum, Edge Computing and Satellite Seen as Longer-Term Drivers Cavanagh pointed to future spectrum auctions as potential long-term sources of equipment deployments and leasing growth. The Federal Communications Commission adopted a plan to auction 160 megahertz of Upper C-band spectrum beginning in April 2027. Combined with previously auctioned Lower C-band spectrum, the auction would create 440 megahertz of contiguous mid-band spectrum for wireless use.

He said the FCC’s build-out conditions, including population-coverage requirements and automatic license termination for failure to meet a later benchmark, should encourage spectrum holders to deploy their licenses. However, Cavanagh said the new spectrum opportunities are more likely to affect results over the next five or more years rather than materially influence next year’s leasing growth.

SBA also sees potential opportunities in edge computing. Cavanagh said the company is speaking with multiple parties interested in more distributed computing architectures that use power- and fiber-connected locations to reduce latency, improve redundancy and support artificial intelligence-oriented applications. He said developments could emerge over the next 12 months, though he did not identify customers or provide financial estimates.

Management said roughly half of SBA’s U.S. portfolio could be well suited to the edge-computing uses currently under discussion. The facilities being considered would generally be smaller than one-megawatt deployments, Cavanagh said.

On satellite direct-to-device services, Cavanagh said SBA views satellite connectivity as complementary to terrestrial wireless networks rather than a replacement. He said satellite providers seeking to offer ubiquitous, high-quality service competitive with traditional mobile networks would likely need terrestrial network components. SBA has spoken with multiple satellite providers, he said, but characterized the discussions as early stage.

While some rural or fringe tower locations could face competitive pressure from satellite service, Cavanagh said SBA’s internal analysis suggests those sites represent no more than roughly 2% to 3% of its portfolio, while satellite data could also help identify locations where additional terrestrial infrastructure is needed.

About SBA Communications (NASDAQ:SBAC)SBA Communications Corporation NASDAQ: SBAC is a real estate investment trust that owns, operates and develops wireless communications infrastructure. Its core business is the leasing of space on communications towers, rooftop sites and other wireless structures to mobile network operators, broadband providers and other wireless service customers. The company also provides site development, construction and ongoing site management services to support the deployment and operation of wireless networks.

In addition to traditional macro towers, SBA offers a range of infrastructure solutions designed for dense urban and suburban markets, including small cells, distributed antenna systems (DAS) and fiber backhaul and transport services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in SBA Communications Right Now?Before you consider SBA Communications, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBA Communications wasn't on the list.

While SBA Communications currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Oneok Inc. (OKE - Free Report) reported $12.05 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 52.8%. EPS of $1.53 for the same period compares to $1.34 a year ago.

The reported revenue represents a surprise of +13.03% over the Zacks Consensus Estimate of $10.66 billion. With the consensus EPS estimate being $1.39, the EPS surprise was +10.07%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Oneok performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Raw feed throughput - Natural Gas Liquids: 1,630.00 MBBL/d versus 1,528.46 MBBL/d estimated by two analysts on average.Adjusted EBITDA- Natural Gas Liquids: $659 million versus $717.28 million estimated by two analysts on average.Adjusted EBITDA- Refined Products & Crude: $627 million compared to the $562.39 million average estimate based on two analysts.Adjusted EBITDA- Natural Gas Pipelines: $297 million compared to the $276.42 million average estimate based on two analysts.Adjusted EBITDA- Natural Gas Gathering and Processing: $546 million versus $546.41 million estimated by two analysts on average.View all Key Company Metrics for Oneok here>>>

Shares of Oneok have returned +3.4% over the past month versus the Zacks S&P 500 composite's +0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Gulfport Energy (GPOR - Free Report) came out with quarterly earnings of $3.91 per share, missing the Zacks Consensus Estimate of $3.94 per share. This compares to earnings of $4.24 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -0.76%. A quarter ago, it was expected that this natural gas producer would post earnings of $7.72 per share when it actually produced earnings of $7.28, delivering a surprise of -5.7%.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

Gulfport, which belongs to the Zacks Oil and Gas - Exploration and Production - United States industry, posted revenues of $323.23 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 8.42%. This compares to year-ago revenues of $447.62 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Gulfport shares have lost about 22.4% since the beginning of the year versus the S&P 500's gain of 9.4%.

What's Next for Gulfport?While Gulfport has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Gulfport was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $5.44 on $342.05 million in revenues for the coming quarter and $23.05 on $1.46 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Oil and Gas - Exploration and Production - United States is currently in the bottom 13% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, HighPeak Energy, Inc. (HPK - Free Report) , is yet to report results for the quarter ended June 2026.

This company is expected to post quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of -70%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

HighPeak Energy, Inc.'s revenues are expected to be $274.1 million, up 36.8% from the year-ago quarter.

Ichor NASDAQ: ICHR reported second-quarter revenue of $294.8 million, up 15% sequentially, as demand strengthened across semiconductor equipment markets and the company continued efforts to expand internal manufacturing and improve margins.

The company said isolated part shortages late in the quarter delayed recognition of some revenue until shortly after the June 26 quarter-end. Ichor said it surpassed $300 million in revenue for the 13 weeks ended July 3 and has since resolved the shortages.

Get Ichor alerts:

Phil Barros said the company now expects a steeper demand ramp in the second half of 2026 than it forecast three months earlier. Ichor expects sequential revenue growth of more than 10% in each of the next two quarters and second-half revenue volumes at least 25% above first-half levels.

“Our confidence in both the magnitude and the duration of this growth cycle is higher today than at any point during this year,” Barros said, citing investments in advanced etch and deposition applications for AI infrastructure, gate-all-around chip architectures, advanced memory and leading-edge process technologies.

Margins and Earnings Improve All profit and loss measures discussed by the company on the call were non-GAAP measures, according to Chief Financial Officer Greg Swyt. The measures exclude items including share-based compensation, acquired-intangible amortization, non-recurring charges and certain tax items.

Second-quarter gross margin rose 130 basis points sequentially to 14.1%, exceeding the high end of Ichor’s guidance range. Swyt attributed the gain to progress in the company’s machining strategy and a more favorable product mix.

Operating expenses were $25.3 million, while operating margin exceeded 5.5%. Earnings per share reached $0.34 on 36.3 million diluted shares, representing the company’s highest quarterly earnings in three years, according to management.

EBITDA increased more than 50% sequentially to more than $21 million. However, cash from operations was a use of $15.9 million as the company increased inventory to support anticipated customer demand. Swyt said inventory investment would continue in the near term, with inventory turns expected to begin improving in the first half of 2027.

Ichor said it remains on track to improve gross margin by roughly 100 basis points per quarter through the balance of 2026. For the third quarter, it projected gross margin of 14.5% to 15.5%.

Capacity, Internal Content and Malaysia Ramp Management highlighted the company’s manufacturing footprint realignment and its effort to increase the proportion of proprietary Ichor-made content in the systems it builds. Barros said internal content was at about a 25% run rate at the end of the second quarter and is expected to reach about 30% by the end of the third quarter and about 35% by the end of the fourth quarter.

The company said manufacturing transitions remain on schedule, including qualifications at its high-volume Malaysian manufacturing site. During the quarter, Ichor received qualifications from its two major customers for machining and welding operations in Malaysia, according to Barros.

Management said customers are seeking additional internal supply options as they address supply-chain risks. The company said faster-than-normal product qualifications indicate customers are working to reduce those risks.

Ichor said it currently has capacity to support $500 million in quarterly revenue, or roughly $2 billion annually. With targeted investment, including additional clean-room space and machining capacity, management said it believes it can expand capacity within its existing footprint to more than $3 billion annually. Barros clarified that current manufacturing capacity is not a constraint on customer demand.

Capital expenditures totaled $7.8 million in the second quarter. The company expects capital spending to rise in the second half as it accelerates investments in factory clean rooms and machining capacity, while remaining near its target of approximately 3% of revenue.

Liquidity and Third-Quarter Outlook Cash and equivalents totaled $256 million at quarter-end, up $167 million from the first quarter. During the quarter, Ichor completed its $200 million at-the-market equity offering, issuing 2.48 million shares at an average price of $80.70 per share and generating approximately $195 million in net proceeds.

Total debt was $120.6 million at the end of the quarter. Days sales outstanding remained at 32 days and inventory turns were 3.7 times, both similar to the prior quarter.

Third-quarter revenue guidance: $315 million to $345 million. Revenue growth at the midpoint: 12% sequentially and 38% year over year in revenue volumes. Third-quarter EPS guidance: $0.40 to $0.50. Expected third-quarter operating expenses: approximately $25.5 million. Swyt said Ichor expects full-year 2026 operating expenses to rise about 6% from 2025, with nearly all of the increase in research and development. The company expects annual revenue growth of at least 30% from 2025, aligning with what management described as the high end of wafer-fab-equipment market expectations.

Management also pointed to growth in its non-semiconductor operations, particularly commercial space. Barros said the commercial space business grew significantly in the second quarter and is expected to continue growing in the second half following a qualification for a particular part family. He also said aerospace and defense activity was growing, though commercial space was the larger driver.

About Ichor (NASDAQ:ICHR)Ichor Holdings Ltd. is a global supplier of critical subsystems used in the fabrication of semiconductor devices. The company specializes in the design, engineering and manufacturing of gas delivery systems, vacuum pumps and abatement solutions that manage process gases and by-products in wafer-processing tools. Its modular subsystems are designed to integrate with lithography, etch, deposition and cleaning equipment, helping to ensure precise control of gas flow, pressure and purity throughout the chip-manufacturing cycle.

Founded in the mid-1980s and headquartered in Fremont, California, Ichor has expanded its footprint across Asia, Europe and North America.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Ichor Right Now?Before you consider Ichor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ichor wasn't on the list.

While Ichor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Ultra Clean Holdings, Inc. (UCTT) Q2 2026 Earnings Call August 3, 2026 4:45 PM EDT

Company Participants

Rhonda Bennetto - Senior Vice President of Investor Relations
James Xiao - CEO & Director
Sheri Brumm - Chief Financial Officer & Senior VP of Finance

Conference Call Participants

Timothy Arcuri - UBS Investment Bank, Research Division
Yu Shi - Needham & Company, LLC, Research Division
Edward Yang - Oppenheimer & Co. Inc., Research Division
Christian Schwab - Craig-Hallum Capital Group LLC, Research Division

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the Ultra Clean Q2 2026 Earnings Call. [Operator Instructions] This call is being recorded on Monday, August 3, 2026.

I would now like to turn the conference over to Rhonda Bennetto of Investor Relations.

Rhonda Bennetto
Senior Vice President of Investor Relations

Thank you, operator. Good afternoon, everyone, and thank you for joining us. With me today are James Xiao, CEO; Sheri Savage, CFO; and Mike Keogh, CFO beginning August 5. James will begin with some prepared remarks about the industry and highlight some of the opportunities ahead for UCT. Sheri will follow with the financial review, and then we'll open up the call for questions.

Today's call contains forward-looking statements that are subject to risks and uncertainties. For more information, please refer to the Risk Factors section in our SEC filings. All forward-looking statements are based on estimates, projections and assumptions as of today, and we assume no obligation to update them after this call. Discussion of our financial results will be presented on a non-GAAP basis. A reconciliation of GAAP to non-GAAP can be found in today's press release posted on our website.

And with that, I'd like to turn the call over to James. James, please go ahead.

James Xiao
CEO & Director

Thank you, Rhonda, and good afternoon, everyone. We appreciate you

TKO Group, the home of UFC and WWE, saw revenue jump 18% to $1.5 billion for the three months ended in June, beating Wall Street estimates as execs touted its partners Paramount and Netflix, the UFC Freedom 250 match and the World Cup, which buoyed its On Location business.

The stock, which has been taking its knocks this year, jumped in late trading after the earnings report, which included higher forecasts for 2026 full-year revenue and adjusted ebidta, key metrics for investors as executive chair and CEO Ariel Emanuel noted strong momentum heading into the back half of the year.

“Despite a challenging global environment, TKO delivered solid results in Q2,” he said. “Premium live content and experiences are heating up in an increasingly AI-driven world, and our businesses are well positioned to fully capitalize on societal secular tailwinds.”

At UFC, revenue rose by $120 million to $536 million. Higher UFC media rights fees reflected the impact of a key distribution agreement with Paramount that began in January. The league also saw new partners and an increase in fees from renewals vs the year before driven by the UFC Freedom 250 event held at the White House in June. Q2 ticket sales fell, since none were sold for that high-profile event.

As expected, the company ended up taking a hit of about $30 million on the spectacle, but, executives said on a call after earnings, TKO successfully leveraged UFC Freedom 250 to boost its relationships with existing partners and create a point of entry for new categories and formats.

At WWE, revenue rose by $64.7 million to $621 million.

TKO’s IMG segment saw sales up by $48 million to $354.7 million.

TKO net income grew $31 million to $304 million on higher revenue partly offset by increased expense, including $98 million of legal fees and settlement costs associated with stockholder litigation related to WWE.

The company’s adjusted ebitda rose 23% to $649.9 million. Free cash flow of $349.6 million fell by $25.3 million

TKO shares closed up 1.2% ahead of earnings and are about 2% after, at $187.

“From UFC Freedom 250 to the FIFA World Cup, TKO continues to deliver on the biggest stages and this quarter reinforced our 2026 execution story,” said TKO president and COO Mark Shapiro, saying its move to raise full-year guidance reflects “both our performance to date and our confidence in TKO’s multi-year trajectory,”

“Our global fan base is expanding, and we are capitalizing on the commercial promise across ticketing, premium hospitality, marketing partnerships, and financial incentive packages. The demand in the experience economy is undeniable and positions us well for multi-year growth, margin expansion, and overall value creation.”

Shapiro pushed back on speculation that in a period of industry consolidation the company has M&A on its mind, including a possible hookup with Formula One. Totally untrue he said, the company has lots of moving pieces, is growing and fully focused on “execution.”

After delivering strong earnings but receiving mixed initial reactions, the hyperscalers are suddenly surging. Amazon ((AMZN - Free Report) ) and Microsoft ((MSFT - Free Report) ) have rallied roughly 20%–25% from their pre-earnings levels, while Alphabet ((GOOGL - Free Report) ) and Meta Platforms ((META - Free Report) ) have recovered sharply from their post-report lows. What began as another round of anxiety over runaway AI spending has quickly turned into renewed enthusiasm for the companies building the infrastructure behind the boom.

At the beginning of earnings season, however, investors were looking at these results through a very different lens.

Alphabet delivered what was, by almost any operating measure, an exceptional quarter. Revenue increased 24%, operating income climbed 30% and Google Cloud revenue surged 82%, with Cloud operating margins expanding to 35.6%. Yet investors focused overwhelmingly on the company’s $44.9 billion of quarterly capital expenditures and the resulting $5.9 billion free-cash-flow outflow.

Meta faced a similar reaction. Revenue increased 28% year over year, supported by a 14% increase in ad impressions and a 12% increase in average ad prices. But quarterly capital expenditures reached $31.1 billion, leaving the company with just $784 million of free cash flow, down from $8.5 billion a year earlier. Investors again treated the spending as the main story, overlooking the continued strength of the underlying business.

The central question hanging over the entire AI trade was straightforward: What kind of return can these companies ultimately earn on hundreds of billions of dollars of AI investment?

Until Amazon reported, the answer remained somewhat opaque. There were signs of accelerating demand across cloud, advertising and enterprise AI, but investors lacked a clear example connecting the enormous infrastructure buildout to both rapid revenue growth and expanding profits.

Amazon provided that example.

Second-quarter revenue increased 20% to $200.6 billion, while operating income surged 43% to $27.5 billion. More importantly, AWS revenue accelerated 37% to $42.2 billion, its fastest growth in 18 quarters, while AWS operating income jumped 64% to $16.6 billion. Despite the massive investment required to support that growth, the segment produced an operating margin of 39.4%.

The results underneath those headline numbers were even more revealing. Amazon disclosed that its AI business has surpassed a $25 billion annualized revenue run rate and continues to grow at a triple-digit percentage rate. Its custom-chip business, which includes Trainium and Graviton, has also exceeded a $25 billion run rate while growing at a triple-digit pace. AWS as a whole is now operating at a $169 billion annualized revenue rate.

That is what flipped the narrative.

Amazon is still spending aggressively, and its trailing-12-month free cash flow has fallen to a $7.6 billion outflow as infrastructure investment has surged. But the spending is no longer supported only by projections about future AI demand. It is already feeding businesses generating tens of billions of dollars in revenue, growing at exceptional rates and producing substantial operating profits.

Microsoft reinforced the same conclusion. Azure revenue increased 43% during the latest quarter, while annual Azure revenue surpassed $100 billion after growing 41% for the fiscal year. Microsoft Cloud generated $59.3 billion of quarterly revenue, up 27%, and Microsoft 365 Copilot surpassed 30 million paid seats, up from 20 million a year earlier.

We still do not have a complete answer to the AI ROI question. Amazon and Microsoft have demonstrated that the hyperscalers can monetize the infrastructure layer through cloud consumption, custom silicon, software subscriptions and enterprise services. The remaining uncertainty rests more heavily with the AI labs themselves, including OpenAI, Anthropic and their competitors where the ultimate margins, pricing power and economics of training and serving increasingly capable models remain less visible.

But the burden of proof has shifted. The hyperscalers are no longer merely promising that AI investment will eventually produce attractive returns. Amazon just gave investors their clearest evidence yet that those returns are already beginning to appear.